In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

POSCO Holdings Inc.’s PKX unit POSCO Future M has invested in a U.S.-based all-solid-state battery company, Factorial, further strengthening the partnership that was entered into following the MOU ...

Posco Future M has invested in US-based battery cell maker Factorial as part of its efforts to gain an edge in the all-solid-state battery market, the company said Tuesday. The Korean battery ...

Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...

Posco Future M, the battery materials subsidiary of South Korea’s steel and chemicals firm Posco Group, announced it has made a strategic investment in Factorial Inc, a US-based developer of materials ...